Clinicopathologic Evaluation of Patients with Recurrence of Gastric Cancer within 6 Months after Curative Resection

被引:1
作者
Cho, Jeong Nam [1 ]
Kim, Yong Ho [1 ]
机构
[1] Kyung Hee Univ, Coll Med, Dept Surg, Seoul, South Korea
来源
JOURNAL OF THE KOREAN SURGICAL SOCIETY | 2009年 / 77卷 / 06期
关键词
Early recurrence; Curative resection; Gastric cancer; MULTIVARIATE-ANALYSES; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; TUMOR RECURRENCE; CARCINOMA; ADENOCARCINOMA; GASTRECTOMY; SURGERY; STOMACH; DEATH;
D O I
10.4174/jkss.2009.77.6.385
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Evaluation of the clinicopathologic characteristics of recur-red gastric cancer after curative resection is useful for detection of the recurrence and care thereof. The aim of this study was evaluating the characteristic's of recurrence that occur less than 6 months after Curative resection for gastric cancer. Methods: The study included 199 patients who recurred after curative gastrectomy that was performed in Kyung-Hee University Medical Center, from January 2000 to January 2008. Clinicopathologic findings were compared between 18 patients who recurred within 6 months after gastrectomy (early recurrence group) and 56 patients who recurred 2 years later (late recurrence group). Results: When compared with the late recurrence group, the early recurrence group was characterized by extended lymph node metastasis (P=0.005), advanced stage of disease (P=0.022), shorter survival period after recurrence (P=0.001), and more hepatic metastasis (P=0.008). Conclusion: Patients with more advanced stages of disease or those with extended lymph node metastasis have a risk of early recurrence after curative gastrectomy. Clinicopathologic characteristics related to recurrence time of gastric cancer are important in detection and effective care of recurred gastric cancer. (J Korean Surg Soc 2009;77:385-390)
引用
收藏
页码:385 / 390
页数:6
相关论文
共 29 条
[1]  
Adachi Y, 2000, CANCER-AM CANCER SOC, V89, P1418
[2]  
Adachi Y, 1996, CANCER, V77, P2445, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2445::AID-CNCR5>3.0.CO
[3]  
2-L
[4]   DUKESS CLASSIFICATION - A VALID PROGNOSTIC INDICATOR FOR GASTRIC-CANCER [J].
ADACHI, Y ;
MORI, M ;
MAEHARA, Y ;
SUGIMACHI, K .
GUT, 1994, 35 (10) :1368-1371
[5]  
BOZZETTI F, 1986, SURG GYNECOL OBSTET, V162, P229
[6]   Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC) [J].
Cavanna, Luigi ;
Artioli, Fabrizio ;
Codignola, Claudio ;
Lazzaro, Antonio ;
Rizzi, Anna ;
Gamboni, Alessandro ;
Rota, Luigina ;
Rodino, Carmelina ;
Boni, Fabrizio ;
Iop, Aldo ;
Zaniboni, Alberto .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04) :371-375
[7]   GASTRIC ADENOCARCINOMA - PROGNOSTIC-SIGNIFICANCE OF SEVERAL PATHOLOGICAL PARAMETERS AND HISTOLOGIC CLASSIFICATIONS [J].
DAVESSAR, K ;
PEZZULLO, JC ;
KESSIMIAN, N ;
HALE, JH ;
JAUREGUI, HO .
HUMAN PATHOLOGY, 1990, 21 (03) :325-332
[8]   TOTAL VERSUS SUBTOTAL GASTRECTOMY FOR ADENOCARCINOMA OF THE GASTRIC ANTRUM - A FRENCH PROSPECTIVE CONTROLLED-STUDY [J].
GOUZI, JL ;
HUGUIER, M ;
FAGNIEZ, PL ;
LAUNOIS, B ;
FLAMANT, Y ;
LACAINE, F ;
PAQUET, JC ;
HAY, JM .
ANNALS OF SURGERY, 1989, 209 (02) :162-166
[9]   PATHOLOGICAL CHARACTERISTICS OF GASTRIC-CANCER THAT DEVELOP HEMATOGENOUS RECURRENCE, WITH SPECIAL REFERENCE TO THE SITE OF RECURRENCE [J].
KOGA, S ;
TAKEBAYASHI, M ;
KAIBARA, N ;
NISHIDOI, H ;
KIMURA, O ;
KAWASUMI, H ;
MAKINO, M .
JOURNAL OF SURGICAL ONCOLOGY, 1987, 36 (04) :239-242
[10]   Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. [J].
Macdonald, JS ;
Smalley, SR ;
Benedetti, J ;
Hundahl, SA ;
Estes, NC ;
Stemmermann, GN ;
Haller, DG ;
Ajani, JA ;
Gunderson, LL ;
Jessup, JM ;
Martenson, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10) :725-730